Patenting genetic materials' unresolved issues and promoting competition in biotechnology

Information Economics and Policy

Volumn 16, Issue 1, 2004, Pages 91-112

  Lawson, Charles ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Access; Competition; Discovery; Genetic materials; Non obviousness; Patent

Indexed keywords

COMPETITION; INTELLECTUAL PROPERTY; LAWS AND LEGISLATION;

GENETIC MATERIALS; INNOVATIONS;

PATENTS AND INVENTIONS;

ACCESSIBILITY; BIOTECHNOLOGY; COMPETITION (ECONOMICS); LEGAL SYSTEM;

EID: 1842482907     PISSN: 01676245     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.infoecopol.2003.09.006     Document Type: Article

References (30)

1. Caufield T. Cherniawsky K. Nelson E. Patent law and human DNA: current practice Knoppers B. Caufield T. Kinsella T. Legal Rights and Human Genetic Material 1996 Edmond Montgomery Limited Publications Toronto
2. Commonwealth of Australia, 1984. Patents, Innovation and Competition in Australia. Industrial Property Advisory Committee
3. Commonwealth of Australia, 1998a. Australian patents for plants
4. Commonwealth of Australia, 1998b. Australian Patents for: Microorganisms, cell lines, hybridomas, related biological materials and their use, genetically manipulated organisms
5. Commonwealth of Australia, 2000a. National Biotechnology Strategy
6. Commonwealth of Australia, 2000b. Access to Biological Resources in Commonwealth Areas. Voumard Committee
7. Commonwealth of Australia, 2000c. Review of Intellectual Property Legislation under the Competition Principles Agreement. Intellectual Property and Competition Review Committee
8. Commonwealth of Australia, 2001a. Government Response to the Intellectual Property and Competition Review Committee Recommendations
9. Commonwealth of Australia, 2001b. Parliamentary Debates. House of Representatives (24 May 2001
10. Parliamentary Secretary to the Minister for Industry, Science and Resources)
11. Conference of Parties to the Convention on Biological Diversity, 2001. Report of the ad hoc open-ended working group on access and benefit sharing, UNEP/CBD/COP/6/6 (including the Annex - Bonn Guidelines on Access to Genetic Resources and Fair and Equitable Sharing of the Benefits Arising out of their Utilisation)
12. Council for Trade-Related Aspects of Intellectual Property Rights, 2001. Submission by the African Group, Barbados, Bolivia, Brazil, Cuba, Dominican Republic, Ecuador, Honduras, India, Indonesia, Jamaica, Pakistan, Paraguay, Philippines, Peru, Sri Lanka, Thailand and Venezuela, IP/C/W/296
13. Dorozynski A. France challenges patent for genetic screening of breast cancer British Medical Journal 323 2001 589
14. Fletcher J. Wertz D. Ethics, law and medical genetics: after the human genome is mapped Emory Law Journal 39 1990 747-749
15. Lawson C. Patenting genes and gene sequences in Australia Journal of Law and Medicine 5 1998 364-371
16. Lawson C. Patenting genetic diversity - old rules may be restricting the exploitation of a new technology Journal of Law and Medicine 6 1999 373-388
17. Lawson C. Canada v europe union - competition and patents at the WTO ACCC Journal 28 2000 1-5
18. Lawson C. Patents, substitution, imitation and competition: Amgen, TKT and the erythropoietin patents ACCC Journal 37 2001 22-24
19. Lawson C. Patenting genes and gene sequences and competition: patenting at the expense of competition Federal Law Review 30 2002 97-133
20. Lawson C. Downing S. It's patently absurd - benefit sharing genetic resources from the seas according to UNCLOS, the CBD and TRIPs Journal of International Wildlife Law and Policy 5 2002 211-233
21. Lawson C. Pickering C. Patent laws will undermine access provisions in the environment protection and biodiversity conservation bill 1998 (Cth) Environmental and Planning Law Journal 15 1998 401-409
22. Lawson C. Pickering C. Patenting genetic materials - failing to reflect the value of variation in DNA, RNA and amino acids Australian Intellectual Property Journal 11 2000 69-82
23. Lawson C. Pickering C. The conflict for patented genetic materials under the convention on biological diversity and the agreement on trade related aspects of intellectual property rights Australian Intellectual Property Journal 12 2001 104-115
24. Lawson C. Pickering C. Controlling access to genetic resources under the environment protection and biodiversity conservation act 1999 requires an assessment of the effects of the patents act 1990 Australian Intellectual Property Journal 13 2002 109-120
25. McCarthy T. Intellectual property and trade practices policy: coexistence or conflict? The American experience Australian Business Law Review 13 1985 198-216
26. Nicol D. Nielsen J. The Australian medical biotechnology industry and access to intellectual property: issues for patent law development Sydney Law Review 23 2001 347-374
27. Nuffield Council on Bioethics, 2002. The Ethics of Patenting DNA - A Discussion Paper. Nuffield Foundation, London
28. Stoianoff N. Access to Australia's biological resources and technology transfer European Intellectual Property Review 20 1998 298-305
29. United States Patent and Trademark Office, 2001. Utility Examination Guidelines, Federal Register 66, pp. 1092-1099
30. Watson R. MEPs protest at patent for breast cancer gene British Medical Journal 323 2001 888